Zynex/ZYXI

$11.95

0.34%
-
1D1W1MYTD1YMAX

About Zynex

Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.

Ticker

ZYXI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Thomas Sandgaard

Employees

1,100

Headquarters

Englewood, United States

Zynex Metrics

BasicAdvanced
$380.28M
Market cap
44.49
P/E ratio
$0.27
EPS
0.45
Beta
-
Dividend rate
$380.28M
0.45489
$14.75
$6.88
229.13K
4.741
4.034
125.869
126.294
30.916
9.85%
7.68%
17.3%
9.11%
44.487
2.063
8.633
21.644
22.982
16.54%
-39.48%
32.01%
4.48%

What the Analysts think about Zynex

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
66.36% upside
High $27.00
Low $15.00
$11.95
Current price
$19.88
Average price target

Zynex Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
2.54% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$47.2M
-5.41%
Net income
$1.2M
-65.71%
Profit margin
2.54%
-63.77%

Zynex Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 23.53%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.04
$0.09
$0.10
$0.21
-
Expected
$0.01
$0.05
$0.09
$0.17
$0.03
Surprise
200.01%
100%
7.14%
23.53%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Zynex stock?

Zynex (ZYXI) has a market cap of $380.28M as of April 15, 2024.

What is the P/E ratio for Zynex stock?

The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 44.49 as of April 15, 2024.

Does Zynex stock pay dividends?

No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next Zynex dividend payment date?

Zynex (ZYXI) stock does not pay dividends to its shareholders.

What is the beta indicator for Zynex?

Zynex (ZYXI) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Zynex stock price target?

The target price for Zynex (ZYXI) stock is $19.88, which is 67.91% above the current price of $11.84. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Zynex stock

Buy or sell Zynex stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing